Cascades Capital Asset Management, LLC

Position in LLY — ELI LILLY & Co

CIK 2035512 GREENSBORO, NC

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,045,353

+$606,123 QoQ

Shares Held

2,539

-4.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.12%

of 13F equity value

Holder Rank

#2,115

of 4,605 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cascades Capital Asset Management, LLC holds $6,734,291 across 6 Drug Manufacturers - General names. LLY ranks #1 (45.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,539	$3,045,353
2	ABBV	AbbVie Inc.	5,690	$1,431,831
3	JNJ	Johnson & Johnson	3,461	$878,990
4	AMGN	Amgen Inc	2,146	$777,109
5	MRK	Merck & Co., Inc.	3,016	$387,556
6	NVS	Novartis AG	1,362	$213,452

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,045,353	2,539	-4.3%	Shares	Sole	2026-08-14
2026-03-31	$2,439,230	2,652	-5.3%	Shares	Sole	2026-05-15
2025-12-31	$3,008,029	2,799	-3.6%	Shares	Sole	2026-02-04
2025-09-30	$2,215,752	2,904	+2.1%	Shares	Sole	2025-11-14
2025-06-30	$2,217,762	2,845	+12.2%	Shares	Sole	2025-08-14
2025-03-31	$2,094,507	2,536	-3.1%	Shares	Sole	2025-05-15
2024-12-31	$2,021,096	2,618	-1.6%	Shares	Sole	2025-02-13
2024-09-30	$2,357,486	2,661	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.